−15.7
Vivos Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−19.6
FY23:
−11.9
FY24:
−12.7
FY25:
−15.3
Change from FY21 to FY25
millions USD
FY21:
−2.61
FY22:
−0.92
FY23:
−0.85
FY24:
−0.57
FY25:
−7.53
Change from FY21 to FY25
millions USD
FY21:
24.2
FY22:
–
FY23:
10.9
FY24:
17.9
FY25:
18.6
millions USD
FY21:
5.82
FY22:
−20.5
FY23:
−1.88
FY24:
4.62
FY25:
−4.23
(positive)
Change from FY21 to FY25
millions USD
FY21:
−18.1
FY22:
−20.5
FY23:
−12.7
FY24:
−13.3
FY25:
−17.6
All amounts in millions USD